Brooke Beery is Associate Editor of Optometry Times®.
Optometry Times® news summary 1/17/2021
Optometry news updates
How to avoid patient nonadherence
Learn more on why patients fail to follow doctors’ recommendations and how to improve patient adherence in eye care.
Poll: Which major industry meeting do you expect to be held in-person in 2021?
This poll is for optometrists and eyecare professionals, only. It will close on Friday, January 29, 2021.
EssilorLuxottica launch first U.S. joint product after merger
RayBan Authentic offers new lens technology and customization
Poll Results: Which of these did your practice experience in 2020?
See our latest poll results
Poll: Do you plan to get immunized for COVID-19?
This poll is for optometrists and eyecare professionals, only. It will close on Friday, January 22, 2021.
Top 10 stories of 2020
It’s another Optometry Times® holiday tradition: the end-of-year top stories list.
Podcast: Optometry Times® news summary 12/31/2020
Optometry Times® news summary 12/31/2020
ODs: Here's what your patients tweeted about you in December 2020
Find out what your patients are tweeting about you
Look back at contact lenses in 2020
Dr. Casella and Gretchyn cover new contact lens technology, specialty lenses, myopia and more.
Poll: Which of these did your practice experience in 2020?
This poll is for optometrists and eyecare professionals, only. It will close on Friday, January 1, 2021.
Poll Results: How much more online CE have you taken due to COVID-19?
Quiz: Know the ocular effects of eyelash growth serums
quick quiz
Quiz answers: Know the ocular effects of eyelash growth serums
ODs: Here's what your patients tweeted about you in November 2020
Poll results: What is your favorite Thanksgiving food?
Poll: How much more online CE have you taken due to COVID-19?
This poll is for optometrists and eyecare professionals, only. It will close on Friday, December 11, 2020.
Poll results: How is your practice performing year-to-date in 2020?
FDA issues Lilly’s arthritis drug baricitinib emergency approval for COVID-19 treatment
When used in combination with remdesivir, baricitinib helps COVID-19 patients recover faster
Quiz: Treatments for presbyopia coming soon
ODs discuss safety ratings in their states this Thanksgiving
COVID-19 is hitting some states harder than others
Quiz Answers: Treatments for presbyopia coming soon
Novel agents in the pipeline for DED
Agents in the pipeline for DED
Overlapping diseases and COVID-19's impact
Counseling and formulary concerns for DED therapies
Challenges in the management of DED
Treatments for aqueous dry eye
In-office procedures and patient resistance for DED treatments